Phlow
Phlow is a U.S.-based CDMO that provides a resilient supply of life-changing medicines and has delivered over two million doses of essential generic medicines to the U.S. Strategic National Stockpile.
Company Profile
Phlow is a company dedicated to providing a resilient and reliable supply of life-changing medicines. The company operates advanced manufacturing facilities in Richmond and Petersburg, Virginia, and focuses on ensuring a domestic supply chain for critical medications. As a certified B Corporation, Phlow emphasizes its commitment to social and environmental performance.
Services
Phlow operates a U.S.-based next-generation Contract Development and Manufacturing Organization (CDMO) that offers research and development (R&D) services for Active Pharmaceutical Ingredients (APIs) and Key Starting Materials. Additionally, the company specializes in innovative continuous manufacturing R&D services tailored for small molecule pharmaceutical product development.
Government Collaboration
Phlow has actively collaborated with the U.S. Government to rebuild a resilient domestic supply chain for critical medicines. This collaboration underscores the company's dedication to national health security and its role in ensuring the availability of essential medications.
Strategic National Stockpile Contributions
Phlow has significantly contributed to the U.S. Strategic National Stockpile by delivering over two million doses of essential generic medicines. This effort highlights Phlow's capability in addressing the immediate and critical medication needs of the country.
Funding and Expansion
Phlow has successfully raised over $35 million in Series B funding aimed at improving the U.S. medicine supply chain. This financial backing supports Phlow's mission to enhance the reliability and accessibility of essential medicines within the United States.
Product Portfolio
Phlow's product portfolio is particularly focused on pediatric patients, addressing drug shortages in children's hospitals. The company's efforts in this area demonstrate a commitment to catering to the specific healthcare needs of vulnerable populations, thereby contributing to better health outcomes for children.